Eric Shifrut is a senior lecturer at Tel Aviv University and a principal investigator at Tel Aviv Sourasky Medical Center. Eric completed his graduate studies under the mentorship of Prof. Nir Friedman at the Weizmann Institute of Science, mapping the TCR repertoire in health and disease.
For his postdoctoral training, he joined Alex Marson at UCSF and Gladstone Institutes to pioneer CRISPR discovery platforms to study primary human T cells.
Today, Eric leads an independent team with the mission to leverage these achievements in CRISPR engineering to design best-in-class T cell therapies against cancer.
Affiliation:
Dotan center for Advanced Therapies, Tel Aviv Sourasky Medical Center
Faculty of Medicine, Department of Pathology, Tel Aviv University
Faculty of Life Sciences, School of Neurobiology, Biochemistry and Biophysics, Tel Aviv University
Contact information:
Email: eshifrut@tauex.tau.ac.il
Lab website: www.shifrut-lab.org
Twitter: @ShifrutLab
